Human immunodeficiency virus infection and left ventricular assist devices

A case series

Daniel B. Sims, Nir Uriel, José González-Costello, Mario C. Deng, Susan W. Restaino, Maryjane A. Farr, Hiroo Takayama, Donna M. Mancini, Yoshifumi Naka, Ulrich P. Jorde

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Historically, advanced heart failure therapies were considered inappropriate for patients infected with human immunodeficiency virus (HIV). As HIV has become a chronic illness with the advent of highly active anti-retroviral therapy (HAART), cardiac transplantation has been used for selected HIV patients with end-stage heart failure. We present a case series describing the clinical outcomes with left ventricular assist device (LVAD) use in 4 patients with HIV. Three of the patients are alive: 1 after a successful bridge to transplant and the other 2 on continued device support at 18 and 13 months after implantation. No infectious complications occurred in 3 patients, and no opportunistic infections occurred in the fourth patient. De novo allosensitization did not occur in our patients after LVAD implantation. With the ongoing donor shortage, implantation of an LVAD in advanced heart failure patients with HIV with controlled viremia on HAART represents a viable option.

Original languageEnglish (US)
Pages (from-to)1060-1064
Number of pages5
JournalJournal of Heart and Lung Transplantation
Volume30
Issue number9
DOIs
StatePublished - Sep 2011
Externally publishedYes

Fingerprint

Heart-Assist Devices
Virus Diseases
HIV
Heart Failure
Viremia
Opportunistic Infections
Heart Transplantation
Chronic Disease
Therapeutics
Tissue Donors
Transplants
Equipment and Supplies

Keywords

  • allosensitization
  • chronic heart failure
  • human immunodeficiency virus
  • left ventricular assist device
  • thrombosis

ASJC Scopus subject areas

  • Transplantation
  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Human immunodeficiency virus infection and left ventricular assist devices : A case series. / Sims, Daniel B.; Uriel, Nir; González-Costello, José; Deng, Mario C.; Restaino, Susan W.; Farr, Maryjane A.; Takayama, Hiroo; Mancini, Donna M.; Naka, Yoshifumi; Jorde, Ulrich P.

In: Journal of Heart and Lung Transplantation, Vol. 30, No. 9, 09.2011, p. 1060-1064.

Research output: Contribution to journalArticle

Sims, DB, Uriel, N, González-Costello, J, Deng, MC, Restaino, SW, Farr, MA, Takayama, H, Mancini, DM, Naka, Y & Jorde, UP 2011, 'Human immunodeficiency virus infection and left ventricular assist devices: A case series', Journal of Heart and Lung Transplantation, vol. 30, no. 9, pp. 1060-1064. https://doi.org/10.1016/j.healun.2011.03.004
Sims, Daniel B. ; Uriel, Nir ; González-Costello, José ; Deng, Mario C. ; Restaino, Susan W. ; Farr, Maryjane A. ; Takayama, Hiroo ; Mancini, Donna M. ; Naka, Yoshifumi ; Jorde, Ulrich P. / Human immunodeficiency virus infection and left ventricular assist devices : A case series. In: Journal of Heart and Lung Transplantation. 2011 ; Vol. 30, No. 9. pp. 1060-1064.
@article{09ba11daee174d8eadfa2720b82a6e28,
title = "Human immunodeficiency virus infection and left ventricular assist devices: A case series",
abstract = "Historically, advanced heart failure therapies were considered inappropriate for patients infected with human immunodeficiency virus (HIV). As HIV has become a chronic illness with the advent of highly active anti-retroviral therapy (HAART), cardiac transplantation has been used for selected HIV patients with end-stage heart failure. We present a case series describing the clinical outcomes with left ventricular assist device (LVAD) use in 4 patients with HIV. Three of the patients are alive: 1 after a successful bridge to transplant and the other 2 on continued device support at 18 and 13 months after implantation. No infectious complications occurred in 3 patients, and no opportunistic infections occurred in the fourth patient. De novo allosensitization did not occur in our patients after LVAD implantation. With the ongoing donor shortage, implantation of an LVAD in advanced heart failure patients with HIV with controlled viremia on HAART represents a viable option.",
keywords = "allosensitization, chronic heart failure, human immunodeficiency virus, left ventricular assist device, thrombosis",
author = "Sims, {Daniel B.} and Nir Uriel and Jos{\'e} Gonz{\'a}lez-Costello and Deng, {Mario C.} and Restaino, {Susan W.} and Farr, {Maryjane A.} and Hiroo Takayama and Mancini, {Donna M.} and Yoshifumi Naka and Jorde, {Ulrich P.}",
year = "2011",
month = "9",
doi = "10.1016/j.healun.2011.03.004",
language = "English (US)",
volume = "30",
pages = "1060--1064",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Human immunodeficiency virus infection and left ventricular assist devices

T2 - A case series

AU - Sims, Daniel B.

AU - Uriel, Nir

AU - González-Costello, José

AU - Deng, Mario C.

AU - Restaino, Susan W.

AU - Farr, Maryjane A.

AU - Takayama, Hiroo

AU - Mancini, Donna M.

AU - Naka, Yoshifumi

AU - Jorde, Ulrich P.

PY - 2011/9

Y1 - 2011/9

N2 - Historically, advanced heart failure therapies were considered inappropriate for patients infected with human immunodeficiency virus (HIV). As HIV has become a chronic illness with the advent of highly active anti-retroviral therapy (HAART), cardiac transplantation has been used for selected HIV patients with end-stage heart failure. We present a case series describing the clinical outcomes with left ventricular assist device (LVAD) use in 4 patients with HIV. Three of the patients are alive: 1 after a successful bridge to transplant and the other 2 on continued device support at 18 and 13 months after implantation. No infectious complications occurred in 3 patients, and no opportunistic infections occurred in the fourth patient. De novo allosensitization did not occur in our patients after LVAD implantation. With the ongoing donor shortage, implantation of an LVAD in advanced heart failure patients with HIV with controlled viremia on HAART represents a viable option.

AB - Historically, advanced heart failure therapies were considered inappropriate for patients infected with human immunodeficiency virus (HIV). As HIV has become a chronic illness with the advent of highly active anti-retroviral therapy (HAART), cardiac transplantation has been used for selected HIV patients with end-stage heart failure. We present a case series describing the clinical outcomes with left ventricular assist device (LVAD) use in 4 patients with HIV. Three of the patients are alive: 1 after a successful bridge to transplant and the other 2 on continued device support at 18 and 13 months after implantation. No infectious complications occurred in 3 patients, and no opportunistic infections occurred in the fourth patient. De novo allosensitization did not occur in our patients after LVAD implantation. With the ongoing donor shortage, implantation of an LVAD in advanced heart failure patients with HIV with controlled viremia on HAART represents a viable option.

KW - allosensitization

KW - chronic heart failure

KW - human immunodeficiency virus

KW - left ventricular assist device

KW - thrombosis

UR - http://www.scopus.com/inward/record.url?scp=80051472675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051472675&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2011.03.004

DO - 10.1016/j.healun.2011.03.004

M3 - Article

VL - 30

SP - 1060

EP - 1064

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 9

ER -